Global MedTech CDMO M&A Update
The global MedTech CDMO industry in the first half of 2023 saw a sustained volume of M&A transactions, in line with H2 2022. We have compiled a list of implications of robust market activity indicating a continued high interest of global investors in MedTech CDMO despite a worsening economy and credit crunch.
Download this overview and discover:
- Key market insights and industry dynamics
- Deal activities and their implications
- Factors driving the growth and evolution